Literature DB >> 7049954

Activation of macrophages by products of lymphocytes from normal and syphilitic rabbits.

S A Lukehart.   

Abstract

The production of soluble macrophage-activating factors by lymphocytes from syphilitic and normal rabbits was examined. Culture supernatants of splenic lymphocytes cultured with Treponema pallidum antigens or concanavalin A were incubated with rabbit peritoneal macrophages in vitro. The macrophage monolayers were then washed and infected with log-phase Listeria monocytogenes. Activation of the macrophages by lymphocyte products was measured by the ability of the macrophages to resist intracellular multiplication of Listeria and thus survive infection. Macrophages incubated with supernatants of unstimulated lymphocytes or T. pallidum-stimulated lymphocytes from normal rabbits were unable to resist intracellular multiplication of Listeria. Specifically stimulated lymphocytes from syphilitic rabbits and mitogen-stimulated lymphocytes from both normal and syphilitic rabbits demonstrated a clear ability to produce soluble factors which conferred upon macrophages the ability to limit the intracellular growth of the bacteria. Antigen or mitogen alone was unable to activate the macrophages; the presence of lymphocyte products was required.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049954      PMCID: PMC347491          DOI: 10.1128/iai.37.1.64-69.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Cell-mediated immunity in experimental syphilis in rabbits.

Authors:  M Metzger; J Podwińska; W Smogór
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1977       Impact factor: 4.291

2.  Treponema pallidum within cells of a primary chancre from a human female.

Authors:  J A Sykes; J N Miller; A J Kalan
Journal:  Br J Vener Dis       Date:  1974-02

3.  An electron microscopic study of a syphilitic chancre. Engulfment of Treponema pallidum by plasma cells.

Authors:  H A Azar; T D Pham; A K Kurban
Journal:  Arch Pathol       Date:  1970-08

4.  Electron microscopy of phagocytosis in syphilis and yaws.

Authors:  N M Ovcinnikov; V V Delektorskij
Journal:  Br J Vener Dis       Date:  1972-08

5.  Effect of cortisone administration on host-parasite relationships in early experimental syphilis.

Authors:  S A Lukehart; S A Baker-Zander; R M Lloyd; S Sell
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

6.  Effect of pretreatment with Mycobacterium bovis (strain BCG) and immune syphilitic serum on rabbit resistance to Treponema pallidum.

Authors:  S R Graves; R C Johnson
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

7.  Reactivity of lymphocytes from patients with syphilis towards T. pallidum antigen in the leucocyte migration and lymphocyte transformation tests.

Authors:  E From; K Thestrup-Pedersen; H Thulin
Journal:  Br J Vener Dis       Date:  1976-08

8.  Effect of sensitization with Propionibacterium acnes on the growth of Listeria monocytogenes and Treponema pallidum in rabbits.

Authors:  R E Baughn; D M Musher; J M Knox
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

9.  Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis.

Authors:  R J Patterson; G P Youmans
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

10.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  12 in total

1.  Contribution of rabbit leukocyte defensins to the host response in experimental syphilis.

Authors:  L A Borenstein; T Ganz; S Sell; R I Lehrer; J N Miller
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

2.  T-Cell responses to Treponema pallidum subsp. pallidum antigens during the course of experimental syphilis infection.

Authors:  T W Arroll; A Centurion-Lara; S A Lukehart; W C Van Voorhis
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 3.  Vaccine development for syphilis.

Authors:  Karen V Lithgow; Caroline E Cameron
Journal:  Expert Rev Vaccines       Date:  2016-07-18       Impact factor: 5.217

4.  Evaluation of the Protective Ability of the Treponema pallidum subsp. pallidum Tp0126 OmpW Homolog in the Rabbit Model of Syphilis.

Authors:  Austin M Haynes; Charmie Godornes; Wujian Ke; Lorenzo Giacani
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

5.  Serum regulation of in vitro lymphocyte responses in early experimental syphilis.

Authors:  S A Baker-Zander; S Sell; S A Lukehart
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

6.  CD4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis.

Authors:  Brandon T Leader; Charmie Godornes; Wesley C VanVoorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

7.  Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8+ T cells?

Authors:  Georg Stary; Irene Klein; Marie-Charlotte Brüggen; Sabine Kohlhofer; Patrick M Brunner; Daniel Spazierer; Leonhard Müllauer; Peter Petzelbauer; Georg Stingl
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

Review 8.  The Th1/Th2-like switch in syphilitic infection: is it detrimental?

Authors:  T J Fitzgerald
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

9.  Cyclophosphamide-sensitive activity of suppressor T cells during treponemal infection.

Authors:  D R Tabor; D P Kiel; R F Jacobs
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

10.  Comparison of CDC and sequence-based molecular typing of syphilis treponemes: tpr and arp loci are variable in multiple samples from the same patient.

Authors:  Lenka Mikalová; Petra Pospíšilová; Vladana Woznicová; Ivana Kuklová; Hana Zákoucká; David Smajs
Journal:  BMC Microbiol       Date:  2013-07-30       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.